Three anti-coronavirus drugs prescribed in Japan, including molnupiravir, may be effective against the omicron subvariant BA.5, according to a study published in the New England Journal of Medicine on Thursday.
A team led by Yoshihiro Kawaoka, a professor of virology at the University of Tokyo, found that small-molecule antiviral drugs nirmatrelvir, molnupiravir and remdesivir curbed virus activity in cultured monkey cells infected with the highly contagious BA.5 and other strains.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
Leave a Reply